Investigations of the efficacy of Microwave tissue ablation (MTA) of primary and secondary lung cancer against comparative treatments radiofrequency ablation (RFA), radiotherapy and surgical resection. The assessment includes three populations these being 
Initial treatment with curative intent, managing disease progression for patients with metastatic disease and control of symptoms during palliative care. 